Cargando...
Bisphosphonate therapy for osteogenesis imperfecta
BACKGROUND: Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal type I collagen bone matrix which typically results in multiple fractures with little or no trauma. Bisphosphonates are used in an attempt to increase bone mineral density and reduce these fractures in people...
Gardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2016
|
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6611487/ https://ncbi.nlm.nih.gov/pubmed/27760454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005088.pub4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|